Pain medicine for newborns during cooling therapy
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests two different pain medicines (dexmedetomidine and morphine) given to newborns during cooling therapy, which is a treatment to help reduce brain injury. The goal is to see which medicine works better for comfort and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be near full term (born at or after 35 weeks of pregnancy).
- Your baby must weigh at least 2500 grams (5.5 pounds) at birth.
- Your baby must show signs of a lack of oxygen around birth and signs of brain injury (neonatal encephalopathy).
- Your baby must start cooling therapy within 8 hours after birth.
- The study team must be able to get your informed consent within 20 hours after birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether cooling a newborn’s body can help babies with mild brain injury after a difficult birth. It aims to see if cooling improves brain-related outcomes compared with standard care.
This trial tests whether a liquid form of the medicine sildenafil can help repair brain damage in newborns who had a difficult birth and were treated with cooling. If your baby meets the cooling criteria and has brain injury on an MRI, this study may offer an additional treatment option.
This study tests a special, non-invasive sensor (near-infrared light) to help doctors choose the best cooling treatment for some newborns after brain injury. It may improve how well cooling works and how safely it’s managed in the first week of life.
This study looks at how children who received cooling treatment for brain injury at birth are doing in the long run. It aims to understand the lasting effects of this treatment, which might help doctors improve care for future babies.
This study compares different approaches to “cooling” treatment in newborns with mild hypoxic-ischemic encephalopathy (mild brain injury from not enough oxygen around birth). The goal is to see which approach works best and is safest for babies like yours.
This trial tests a medicine called dexmedetomidine to keep premature babies calm and comfortable while they are on a breathing machine. It may help reduce pain and stress for your baby during this difficult time.
Hear when a new Hypoxic-Ischemic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.